Prices and Awards
The Frankfurt Foundation Quality of Medicines (FFQM) intends to honor outstanding initiatives and activities in the field of medicinal product quality through awards and prices. This will be realized as an independent initiative as well as in cooperation with national or international Societies and Associations.
Awardees:
Quality of Medicines Award
- 2022 Dr. Cathrin Hauk, Univ. Tübingen
- 2021 Jun.-Prof. Dr. Oliver Scherf-Clavel, Univ. Würzburg
Pearls of Bioequivalence Award
- 2022 Dr. Eduard Molins, Univ. Politecnica Catalunya
- 2021 Prof. Dr. Maria del Val Bermejo Sanz, Univ. Elche, Alicante
The following prizes and awards are planned or already set up:
- „Quality of Medicines Award“ (awarded together with the DPhG)
- „Pearls of Bioequivalence Award“ (awarded together with the EUFEPS Network Bioavailability and Biopharmaceutics)
- „Hans-Günter-Schäfer Award“ (awarded on the occasion of the PK / PD expert meeting)
- „Lifetime Achievement Award“ for outstanding scientists for their contributions to the optimization of the quality of medicines.
Hans-Günter-Schäfer-Award
- 2022 Lukas Kovar, Univ. Saarbrücken
- 2021 Jane Knöchel, Univ. Potsdam
- 2021 Corinna Maier, Univ. Potsdam
Lifetime Achievement Award
- 2020 Prof. Dr. Laszlo Endrenyi, Univ. Toronto
- 2021 Prof. Dr. José Morais, Univ. Lisbon
- 2023 Prof. Dr. Leslie Benet, Univ. San Francisco
May 18, 2023
Congratulations, Prof. Leslie Benet - Lifetime Achievement Award presented
The Frankfurt Foundation Quality of Medicines (FFQM) Lifetime Achievement Award was presented to Professor Leslie Z. Benet of the University of California San Francisco (UCSF) for his outstanding achievements in the field of pharmaceutical science and his contributions to improving the quality and efficacy of medicines awarded.
The award ceremony took place on May 15, 2023 at the end of a scientific congress in the Frankfurt Airport Conference Center. The draft of Part A of the ICH M13 Guideline on Bioequivalence of immediate release dosage forms was discussed and commented on in the „Open Forum“ initiated by the EUFEPS (European Federation for Pharmaceutical Sciences) and organized jointly with the Working Group for Pharmaceutical Process Engineering (APV).
The winner, Professor Benet, was presented with the certificate and the Gömböc, the traditional sculpture for the FFQM Lifetime Achievement Award, by the founder and Chairman of the Foundation, Professor Henning Blume.
Professor Benet is already the third scientist whose life’s work has been honored with a Gömböc by the Frankfurt Foundation Quality of Medicines.
September 29, 2022
Presentation of the "Pearls of Bioequivalence Award" at the GBHI conference in Amsterdam
The Frankfurt Foundation Quality of Medicines (FFQM) and the European Federation for Pharmaceutical Sciences (EUFEPS) honor outstanding contributions to the optimization of concept, design and evaluation of bioequivalence with the „Pearls of Bioequivalence Award“. The decision on the winners is made jointly by the two organizations on the basis of proposals from the steering committee of the EUFEPS Biopharmaceuticals and Bioavailability Network.
The award ceremony for both 2022 and 2021, which had to be postponed due to COVID restrictions, took place at the Global Bioequivalence Harmonization Initiative (GBHI) conference on September 28 in Amsterdam. We congratulate the award winners Prof. Marival Bermejo, Universitat Miquel Hernández de Elche and Dr. Eduard Molins, Universitat Politecnica de Catalunya.
September 18, 2022
Dr. Cathrin Hauk received the “Quality of Medicines Award” 2022
The Frankfurt Foundation Quality of Medicines (FFQM) and the German Pharmaceutical Society (DPhG) awarded the joint »Quality of Medicines Award« at the annual Meeting of the DPhG on September 16th. This year’s award winner is Dr. Cathrin Hauk, University of Oxford/UK. With this prize her dissertation »Investigations and identification options for inferior and counterfeit medicines to improve the quality of medicines in low- and middle income Countries« (Eberhard Karls University of Tübingen) was honored.
Quote from the doctoral thesis: »Securing the quality of medicines worldwide is one of the major health policy challenges of our time and the basis for general health care, which is anchored as goal 3.8 in the Sustainable Development Goals of the United Nations.« We congratulate Dr. Hauk, who made an important contribution to quality transparency with her investigations.
May 22, 2022
Hans Günter Schäfer Science Prize 2020 belated awarded
Since the PKPD Expert Meeting in 2020 had to be cancelled due to the Covid-19 pandemic, the presentation of the Hans Günter Schäfer Award 2020 was made up for at this year’s conference on April 29th in Saarbrücken. The two winners Corinna Maier (AbbVie) and Jane Knöchel (AstraZeneca) share the prize.
May 16, 2022
Hans-Günter-Schäfer-Science Prize 2022 awarded
Pharmacist Lukas Kovar (Boehringer Ingelheim) has been awarded the Hans Günter Schäfer Science Prize 2022. In honor of Dr. Hans Günter Schäfer this prize is awarded for the promotion of young scientists on the occasion of the PKPD expert meeting organized by the Working Group for Applied Human Pharmacology (AGAH). Since this year, the award has been supported by the Frankfurt Foundation Quality of Medicines (FFQM) as a partner of AGAH.
November 22, 2021
Professor Josè Morais honored with Lifetime Achievement Award
In a ceremony on November 13, 2021, the Frankfurt Foundation Quality of Medicines (FFQM) bestowed the “Lifetime Achievement Award” for outstanding scientific contributions to the optimization of drug quality for the first time With this award, the special merits of the award winner Professor Emeritus Dr. Josè Augusto Guimarães Morais, University of Lisbon, recognized for the development of regulatory criteria for the comparative assessment of the bioavailability of systemic drugs. „We are very pleased that we can award the prize to such an outstanding scientist,“ explains the founder and chairman of the foundation, Professor Dr. Henning Blume, who has been committed to promoting drug quality for many years.
November 22, 2021
Junior Professor Oliver Scherf-Clavel awarded with the prize for the “Promotion of Drug Quality”
As part of this year’s annual conference of the German Pharmaceutical Society (DPhG), the prize for the „Promotion of Drug Quality“ was awarded for the first time. This is a joint award by the Frankfurt Foundation Quality of Medicines (FFQM) and the DPhG.
The award winner is junior professor Dr. Oliver Scherf-Clavel, Würzburg, who was honored for his work on the contamination of valsartan and other sartans.
